Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. (Q46616110)
Jump to navigation
Jump to search
scientific article published in May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. |
scientific article published in May 2008 |
Statements
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission (English)
Alexia Iasonos
Sacha Gnjatic
Achim A Jungbluth
Lloyd J Old
Carol Aghajanian
Paul Sabbatini
Martee L Hensley
David R Spriggs
Helen Lee
Bo Dupont
Sandra Pezzulli